John Reed on J&J’s R&D model, recent oncology deals and pipeline expansion potential

Endpoints News interviewed Johnson & Johnson's R&D chief John Reed about his strategy for drug development, acquisitions, obesity and cardiovascular disease.

Raccontata daendpoints.news